0000899243-19-013250.txt : 20190513
0000899243-19-013250.hdr.sgml : 20190513
20190513170035
ACCESSION NUMBER: 0000899243-19-013250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190509
FILED AS OF DATE: 20190513
DATE AS OF CHANGE: 20190513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lundbeckfond Invest A/S
CENTRAL INDEX KEY: 0001591046
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38886
FILM NUMBER: 19819169
BUSINESS ADDRESS:
STREET 1: SCHERFIGSVEJ 7
CITY: COPENHAGEN
STATE: G7
ZIP: DK-2100
BUSINESS PHONE: 4540307375
MAIL ADDRESS:
STREET 1: SCHERFIGSVEJ 7
CITY: COPENHAGEN
STATE: G7
ZIP: DK-2100
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trevi Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450834299
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-304-2499
MAIL ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-09
1
0001563880
Trevi Therapeutics, Inc.
TRVI
0001591046
Lundbeckfond Invest A/S
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 14TH FLOOR
NEW HAVEN
CT
06510
0
0
1
0
Common Stock
2019-05-09
4
C
0
776544
A
776544
D
Common Stock
2019-05-09
4
P
0
375000
10.00
A
1151544
D
Series C Preferred Stock
2019-05-09
4
C
0
6849315
0.00
D
Common Stock
776544
0
D
On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
/s/ Lene Skole, CEO Lundbeckfond Invest A/S
2019-05-09
/s/ Mette Kirstine Agger, Managing Partner, Lundbeckfonden Ventures
2019-05-09